Are you interested in using your lived experience and voice to help us shape the future pulmonary fibrosis research?
Mike Stubbins, from Hertfordshire, brings a wealth of experience to the charity. He has worked in multiple Research & Development roles within the Pharmaceutical Industry. Mike is currently a Programme Lead at Genomics England with the aim of helping everyone benefit from genomic healthcare with a current focus on patients with rare disease and cancer. Mike’s mother, Anne, sadly died of pulmonary fibrosis in 2017.
Louise Wright, CEO, Action for Pulmonary Fibrosis says: “I’d like to acknowledge the huge contribution from our previous Chair Steve Jones. His drive and passion has spearheaded one of the biggest changes for people living with pulmonary fibrosis by enabling access to life-changing anti-fibrotic medicines”.
Talking about Dr Stubbins, Louise continued: “Mike joins us at a pivotal moment as we mark our 10th anniversary year. We’re a fast growing charity determined to widen our reach and influence to change the outcomes for people living with and affected by pulmonary fibrosis. I know Mike’s research and development expertise and lived experience will be invaluable.”
Speaking about his new role, Dr Stubbins said: “I’m a passionate advocate for people living with or affected by pulmonary fibrosis. I’ve experienced first-hand how this disease can devastate the lives of those affected. I know we can collectively increase awareness and understanding of this poorly-understood set of diseases, work with others to improve treatments and ultimately stop PF diseases in their tracks.”
Founding Trustee Elizabeth Bray and her fellow Trustee Howard Almond – who both have lived experience of pulmonary fibrosis – have stepped down as Trustees. They have contributed enormously to the charity as it’s grown over the years.